Common Equity: The sum of all common equity items.
Telix Pharmaceuticals Limited (TLX) had Common Equity of $487.68M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$488.02M |
|
$72.24M |
|
$873.83M |
|
$1.36B |
|
$242.34M |
|
$564.44M |
|
$631.83M |
|
$874.18M |
|
|
Common Equity |
$487.68M |
$-96.94M |
|
$487.68M |
|
339.79M |
|
| Cash Flow Statement Financials | |
$23.04M |
|
$-33.72M |
|
$118.43M |
|
$141.87M |
|
$251.91M |
|
$110.04M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|